Artificial Intelligence In Oncology Market Report 2026

Artificial Intelligence In Oncology Market Overview

• Artificial Intelligence In Oncology market size has reached to $2.35 billion in 2025 • Expected to grow to $10.25 billion in 2030 at a compound annual growth rate (CAGR) of 34.5% • Growth Driver: AI In Oncology Market Surges As Cancer Incidence Continues To Rise • Market Trend: Innovative Cloud-Based Software Revolutionizes AI In Oncology Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence In Oncology Market?

Artificial intelligence in oncology refers to applying artificial intelligence (AI) technologies and techniques in cancer diagnosis, treatment, research, and patient care. The goal of AI in oncology is to improve outcomes for cancer patients by leveraging computational methods to identify patterns, predict outcomes, and support evidence-based decision-making across the continuum of cancer care. The main components of artificial intelligence in oncology are software solutions, hardware, and services. Software solutions in the field of oncology leverage artificial intelligence (AI) to enhance various aspects of cancer diagnosis, treatment, and research. The various treatment types include chemotherapy, radiotherapy, immunotherapy, and others. The various cancer types include breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumor, and others. These are used in various applications such as cancer detection, drug discovery, and drug development, and also by various end-users such as hospitals, diagnostic centers, pharmaceutical companies, research institutes, and others.

What Is The Artificial Intelligence In Oncology Market Growth Forecast?

The artificial intelligence in oncology market size is expected to see exponential growth in the next few years. It will grow to $10.25 billion in 2030 at a compound annual growth rate (CAGR) of 34.5%. The growth in the forecast period can be attributed to increasing adoption of precision oncology solutions, rising demand for personalized cancer therapies, expansion of ai use in clinical oncology trials, growing integration of genomics with ai platforms, increasing investments in oncology-focused ai startups. Major trends in the forecast period include increasing adoption of AI-based cancer detection tools, rising use of ai in treatment planning optimization, growing integration of ai in drug discovery and development, expansion of predictive oncology analytics, enhanced focus on precision oncology applications.

Global Artificial Intelligence In Oncology Market Segmentation

1) By Component: Software Solutions, Hardware, Services 2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types 3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types 4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications 5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users Subsegments: 1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms 2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems 3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

What Is The Driver Of The Artificial Intelligence In Oncology Market?

The rising incidence of cancer cases is expected to propel the growth of the AI in oncology market going forward. Cancer is a complex group of diseases characterized by the uncontrolled growth and division of abnormal cells in the body. The integration of AI into oncology has the potential to revolutionize cancer care by making it more precise, personalized, and efficient. For instance, in 2023, according to a report by the American Cancer Society Inc., a US-based voluntary health organization, the estimated number of new cancer cases increased from 1.8 million to 1.9 million. Therefore, the rising incidence of cancer cases is driving the growth of the AI in oncology market.

Key Players In The Global Artificial Intelligence In Oncology Market

Major companies operating in the artificial intelligence in oncology market are Azra AI, IBM Corporation, Siemens Healthcare GmbH, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Proscia Inc., Deep 6 AI Inc., Intel Corporation, Zebra Medical Vision, Ibex Medical Analytics, Nanox Imaging Ltd., Berg LLC

Global Artificial Intelligence In Oncology Market Trends and Insights

Major companies operating in the AI in the oncology market are focusing on developing innovative software, such as cloud-based software, to enhance their efficacy and provide improved solutions. Cloud-based software plays a crucial role in AI applications in oncology by providing a scalable, flexible, and accessible platform for processing and analyzing large volumes of medical data. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, launched Connected Insights, new cloud-based software enabling tertiary analysis for oncology applications. With the help of the integration of external knowledge bases, Connected Insights streamlines the interpretation and reporting of results from various assay types, allowing labs to expand their usage of NGS (Next-Generation Sequencing) and speed up the turnaround time for clinical reporting.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Oncology Market?

In May 2024, Lunit, a South Korea-based medical solutions company, acquired Volpara Health Technologies for $193 million. This acquisition of Lunit aims to create a formidable alliance in the cancer diagnostics industry, particularly in the U.S. market. By combining their strengths, Lunit seeks to enhance its AI-driven solutions for early cancer detection and improve patient care. Volpara Health Technologies is a New Zealand-based healthcare software company that develops and sells breast cancer detection and diagnosis tools.

Regional Outlook

North America was the largest region in the AI in oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence In Oncology Market?

The artificial intelligence in oncology market consists of revenues earned by entities by providing services such as surgery, targeted therapy, and stem cell transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in the oncology market also includes sales of edge devices, storage devices, field-programmable gate arrays (FPGA), and tensor processing units (TPU). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence In Oncology Market Report 2026?

The artificial intelligence in oncology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in oncology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.